Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Completed · Phase 2

Conditions studied: Glaucoma

In brief

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults with Primary Open Angle Glaucoma or Ocular Hypertension

Key facts

Study ID

NCT07168902

Run by

Bausch & Lomb Incorporated

People needed

252

Starts

2025-10-24

Expected to finish

2026-05-18

Last updated by the study team

2026-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ocular hypertension or primary open-angle glaucoma in each eye

You may not qualify if…

• History of orthostatic hypotension
• Any active ocular disease
• Anticipated wearing of contact lenses during study
• Contraindication to pupil dilation

Where it is running

• Global Research Management, Inc. — Glendale, California, United States
• Eye Research Foundation — Newport Beach, California, United States
• California Eye Specialist Medical Group, LLC — Pasadena, California, United States
• Eye Associates of Fort Myers — Fort Myers, Florida, United States
• Levenson Eye Associates — Jacksonville, Florida, United States
• Central Florida Eye Associates — Lakeland, Florida, United States
• Lee Shettle Eye and Hearing — Largo, Florida, United States
• Clayton Eye Clinical Research, LLC — Morrow, Georgia, United States
• Coastal Research Associates, LLC — Roswell, Georgia, United States
• Heart of America Eye Care — Shawnee Mission, Kansas, United States
• Andover Eye Associates — Andover, Massachusetts, United States
• Scott & Christie and Associates, PC — Cranberry Township, Pennsylvania, United States
• Total Eye Care, P.A. — Memphis, Tennessee, United States
• Houston Eye Associates — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.